publication venue for
- Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): A study protocol of a prospective multicentre cohort study. 10. 2020
- Phase II clinical trial testing the safety of a humanised monoclonal antibody anti-CD20 in patients with heart failure with reduced ejection fraction, ICFEr-RITU2: Study protocol. 9. 2019
- B-type natriuretic peptide reference interval of newborns from healthy and pre-eclamptic women: A prospective, multicentre, cross-sectional study. 8. 2018